ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1423
0,00%
Bitcoin
62.918,10
-0,21%
Brent Oil
84,20
0,30%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Curis Inc (CRIS)

  7. Curis Inc (CRIS) Notícias

CRIS

Curis (CRIS)

Curis Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRIS
DataHoraFonteTítuloCódigoCompanhia
07/05/202409:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
07/05/202409:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
07/05/202409:00PR Newswire (US)Curis Provides First Quarter 2024 Business UpdateNASDAQ:CRISCuris Inc
30/04/202409:00PR Newswire (US)Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024NASDAQ:CRISCuris Inc
05/04/202408:30PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
04/04/202408:30PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in AprilNASDAQ:CRISCuris Inc
12/02/202418:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRISCuris Inc
08/02/202418:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRISCuris Inc
08/02/202418:27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRISCuris Inc
08/02/202418:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRISCuris Inc
08/02/202410:00PR Newswire (US)Curis Provides Fourth Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
01/02/202410:00PR Newswire (US)Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024NASDAQ:CRISCuris Inc
21/12/202318:00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CRISCuris Inc
12/12/202310:00PR Newswire (US)Curis Announces Initial Combination Study Data from its TakeAim Lymphoma StudyNASDAQ:CRISCuris Inc
11/12/202310:00PR Newswire (US)Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH ConferenceNASDAQ:CRISCuris Inc
06/12/202310:00PR Newswire (US)Curis Announces Three Presentations at ASHNASDAQ:CRISCuris Inc
05/12/202310:00PR Newswire (US)Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in MelanomaNASDAQ:CRISCuris Inc
02/11/202309:00PR Newswire (US)Curis Provides Third Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
26/10/202309:30PR Newswire (US)Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023NASDAQ:CRISCuris Inc
28/09/202317:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRISCuris Inc
12/09/202309:00PR Newswire (US)Curis Announces Date for the 2nd Symposium on IRAK4 in CancerNASDAQ:CRISCuris Inc
06/09/202309:13PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in SeptemberNASDAQ:CRISCuris Inc
18/08/202317:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRISCuris Inc
04/08/202317:09Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CRISCuris Inc
03/08/202317:01PR Newswire (US)Curis Provides Second Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
27/07/202319:25PR Newswire (US)Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023NASDAQ:CRISCuris Inc
06/07/202317:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRISCuris Inc
06/07/202309:01PR Newswire (US)FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BIDNASDAQ:CRISCuris Inc
06/07/202309:00PR Newswire (US)Curis Announces $15.1 Million Registered Direct OfferingNASDAQ:CRISCuris Inc
04/05/202317:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRISCuris Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRIS

Seu Histórico Recente

BOV
IFCM3
Infracommerce Caxaas ON
BOV
VVEO3
CM Hospitalar ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
CMIN3
CSN Mineracao S.A ON
BOV
COGN3
COGNA ON
BOV
LUPA3
LUPATECH ON
BOV
PDTC3
Padtec ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
CASH3
Meliuz S.A ON
BOV
RNEW4
RENOVA PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados